/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies.
By Colin Kellaher Elevation Oncology on Thursday said it named Joseph Ferra chief executive, removing the interim tag he has carried since January. Ferra,.
/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies.